Jordi Minguillón

943 total citations
17 papers, 371 citations indexed

About

Jordi Minguillón is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Jordi Minguillón has authored 17 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cell Biology. Recurrent topics in Jordi Minguillón's work include DNA Repair Mechanisms (7 papers), Aldose Reductase and Taurine (3 papers) and CAR-T cell therapy research (2 papers). Jordi Minguillón is often cited by papers focused on DNA Repair Mechanisms (7 papers), Aldose Reductase and Taurine (3 papers) and CAR-T cell therapy research (2 papers). Jordi Minguillón collaborates with scholars based in Spain, United States and Sweden. Jordi Minguillón's co-authors include J. Aramburu, Cristina López-Rodrı́guez, Beatriz Morancho, Salvador Iborra, Maria Buxadé, Margarita Del Val, Katherine Drews‐Elger, Jordi Surrallés, Jeffery D. Molkentin and Seong‐Jin Kim and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and PLoS ONE.

In The Last Decade

Jordi Minguillón

17 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jordi Minguillón Spain 8 172 130 81 46 45 17 371
Patryk Górniak Poland 12 187 1.1× 59 0.5× 56 0.7× 82 1.8× 45 1.0× 26 426
Xiaogang Chu United States 13 198 1.2× 74 0.6× 80 1.0× 34 0.7× 80 1.8× 20 390
Serhan Karvar United States 12 186 1.1× 89 0.7× 31 0.4× 55 1.2× 31 0.7× 18 333
Christoph Weinstock Germany 5 280 1.6× 74 0.6× 95 1.2× 53 1.2× 25 0.6× 5 447
Thor Gehrmann Germany 10 197 1.1× 159 1.2× 29 0.4× 47 1.0× 51 1.1× 11 385
Kelly M. England United States 9 160 0.9× 113 0.9× 127 1.6× 14 0.3× 83 1.8× 9 495
Di Xia China 11 187 1.1× 80 0.6× 42 0.5× 34 0.7× 20 0.4× 23 328
Sharon Aviram Israel 9 228 1.3× 78 0.6× 29 0.4× 28 0.6× 35 0.8× 14 441
Alessandro E. Caccamo Italy 8 189 1.1× 88 0.7× 48 0.6× 163 3.5× 59 1.3× 9 395
Beate Vollenbröker Germany 10 171 1.0× 127 1.0× 27 0.3× 32 0.7× 35 0.8× 15 374

Countries citing papers authored by Jordi Minguillón

Since Specialization
Citations

This map shows the geographic impact of Jordi Minguillón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jordi Minguillón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jordi Minguillón more than expected).

Fields of papers citing papers by Jordi Minguillón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jordi Minguillón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jordi Minguillón. The network helps show where Jordi Minguillón may publish in the future.

Co-authorship network of co-authors of Jordi Minguillón

This figure shows the co-authorship network connecting the top 25 collaborators of Jordi Minguillón. A scholar is included among the top collaborators of Jordi Minguillón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jordi Minguillón. Jordi Minguillón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Minguillón, Jordi, et al.. (2024). Targeting protein-protein interactions in drug discovery: Modulators approved or in clinical trials for cancer treatment. Pharmacological Research. 211. 107544–107544. 6 indexed citations
2.
Martín-Antonio, Beatriz, Belén Blanco, África González‐Murillo, et al.. (2024). Newer generations of multi-target CAR and STAb-T immunotherapeutics: NEXT CART Consortium as a cooperative effort to overcome current limitations. Frontiers in Immunology. 15. 1386856–1386856. 10 indexed citations
3.
4.
Page, Angustias, Anna Suñol, Carmen Segrelles, et al.. (2022). Development of a mouse model for spontaneous oral squamous cell carcinoma in Fanconi anemia. Oral Oncology. 134. 106184–106184. 5 indexed citations
5.
Matamala, Nerea, et al.. (2022). Advanced Molecular Characterisation in Relapsed and Refractory Paediatric Acute Leukaemia, the Key for Personalised Medicine. Journal of Personalized Medicine. 12(6). 881–881. 1 indexed citations
6.
Casado, José Antonio, Antonio Valeri, Rebeca Sánchez‐Domínguez, et al.. (2022). Upregulation of NKG2D ligands impairs hematopoietic stem cell function in Fanconi anemia. Journal of Clinical Investigation. 132(15). 4 indexed citations
7.
Español, Ignacio, et al.. (2021). Fanconi-like anemia related to a FANCM mutation. European Journal of Medical Genetics. 65(1). 104399–104399. 3 indexed citations
8.
Martínez‐Barriocanal, Águeda, José Antonio Casado, Marı́a José Ramı́rez, et al.. (2020). Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia–Related Head and Neck Cancer. Clinical Cancer Research. 26(12). 3044–3057. 21 indexed citations
9.
Rodríguez‐Santiago, Benjamín, Adriana Lasa, Lidia González‐Quereda, et al.. (2020). Novel Somatic Genetic Variants as Predictors of Resistance to EGFR-Targeted Therapies in Metastatic Colorectal Cancer Patients. Cancers. 12(8). 2245–2245. 1 indexed citations
10.
Carreras‐Puigvert, Jordi, Maria Häggblad, Bo Lundgren, et al.. (2020). High content drug screening for Fanconi anemia therapeutics. Orphanet Journal of Rare Diseases. 15(1). 170–170. 1 indexed citations
11.
Ramı́rez, Marı́a José, Jordi Minguillón, Kelly E. Lake, et al.. (2019). Chromosome fragility in the buccal epithelium in patients with Fanconi anemia. Cancer Letters. 472. 1–7. 12 indexed citations
12.
Minguillón, Jordi & Jordi Surrallés. (2018). Therapeutic research in the crystal chromosome disease Fanconi anemia. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 836(Pt A). 104–108. 4 indexed citations
13.
Silva, Gabriela, Bruno A. Cardoso, Beatriz Porto, et al.. (2015). Epigenetic Alterations in Fanconi Anaemia: Role in Pathophysiology and Therapeutic Potential. PLoS ONE. 10(10). e0139740–e0139740. 9 indexed citations
14.
Buxadé, Maria, Jordi Minguillón, Salvador Iborra, et al.. (2012). Gene expression induced by Toll-like receptors in macrophages requires the transcription factor NFAT5. The Journal of Experimental Medicine. 209(2). 379–393. 127 indexed citations
15.
Morancho, Beatriz, Jordi Minguillón, Jeffery D. Molkentin, Cristina López-Rodrı́guez, & J. Aramburu. (2008). Analysis of the transcriptional activity of endogenous NFAT5 in primary cells using transgenic NFAT-luciferase reporter mice. BMC Molecular Biology. 9(1). 13–13. 35 indexed citations
16.
Aramburu, J., et al.. (2006). Regulation of the hypertonic stress response and other cellular functions by the Rel-like transcription factor NFAT5. Biochemical Pharmacology. 72(11). 1597–1604. 99 indexed citations
17.
Minguillón, Jordi, Beatriz Morancho, Seong‐Jin Kim, Miguel López‐Botet, & J. Aramburu. (2005). Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-β1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-β1. Journal of Leukocyte Biology. 77(5). 748–758. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patryk Górniak Breakdown of academic impact, for papers by Xiaogang Chu Breakdown of academic impact, for papers by Serhan Karvar Breakdown of academic impact, for papers by Christoph Weinstock Breakdown of academic impact, for papers by Thor Gehrmann Breakdown of academic impact, for papers by Kelly M. England Breakdown of academic impact, for papers by Di Xia Breakdown of academic impact, for papers by Sharon Aviram Breakdown of academic impact, for papers by Alessandro E. Caccamo Breakdown of academic impact, for papers by Beate Vollenbröker
Rankless by CCL
2026